Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

7.97
-0.1800-2.21%
Post-market: 7.970.00000.00%19:59 EDT
Volume:11.35M
Turnover:90.55M
Market Cap:8.34B
PE:-8.98
High:8.14
Open:8.05
Low:7.81
Close:8.15
52wk High:12.43
52wk Low:1.95
Shares:1.05B
Float Shares:394.00M
Volume Ratio:0.94
T/O Rate:2.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8871
EPS(LYR):-0.3820
ROE:78.05%
ROA:-34.38%
PB:-9.59
PE(LYR):-20.86

Loading ...

May 07, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 09, 2026

Major Issues Report

Form 8-K - Current report
Apr 06, 2026

Major Issues Report

Form 8-K - Current report
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Feb 24, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2026

Proposed Sale Of Securities

Form 144 | ImmunityBio Director Christobel Selecky proposes to sell 25,000 shares, with a total value of approximately $217,500
Feb 23, 2026

Major Issues Report

Form 8-K - Current report
Feb 18, 2026

Major Issues Report

Form 8-K - Current report
Jan 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 21, 2026

Proposed Sale Of Securities

Form 144 | IMMUNITYBIO's Director Christobel Selecky proposes to sell 25000 shares, with a total value of approximately $138,000.
Jan 20, 2026

Proposed Sale Of Securities

Form 144 | ImmunityBio's Officer and Director Simon Barry J. proposes to sell 571,967 Shares, with a total value of approximately $5.90 Million.
Jan 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2026

Major Issues Report

Form 8-K - Current report
Jan 14, 2026

Major Issues Report

Form 8-K - Current report
Dec 24, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2025

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]